Panelists discuss how payers typically require step therapy with SGLT2 inhibitors before approving nonsteroidal MRAs due to ...
Misdiagnosis or underdiagnosis of rare diseases in patients with diagnoses of common diseases can lead to delayed or inappropriate treatments, thereby complicating the management of both rare and ...
RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held clinical-stage biopharmaceutical company leading the development of innovative, ...
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each ...
As Tubulis prepares to unveil the first in-human data on its next-generation antibody drug conjugate (ADC) later this month, the German biotech has secured a massive new financing round to kick its ...
Mastermind participant Christina Slemp of Community Health Systems explains how RCM leaders need to balance the potential of AI with the damage it can do if not managed properly.
The rapid development and integration of artificial intelligence (AI), including predictive, generative, and emerging agentic ...
Merger creates $600-million-revenue data infrastructure company Fivetran CEO Fraser to lead combined company Deal highlights AI-driven data infrastructure demand Oct 13 (Reuters) - Data startups ...
Regeneron has posted updated clinical data on DB-OTO, providing more evidence of the gene therapy’s potential to treat a rare genetic form of deafness as it plans for a potential FDA filing later this ...
NEW YORK--(BUSINESS WIRE)--Macquarie Asset Management, on behalf of two of its privately managed infrastructure funds along with its co-invest partners, has agreed to the sale of Aligned Data Centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback